GO
Loading...

AstraZeneca PLC

More

  • LONDON, May 7- Britain should consider whether existing takeover laws giving ministers power to intervene in deals could be applied to U.S. drugmaker Pfizer's approach for London- listed AstraZeneca, Prime Minister David Cameron's spokesman said on Wednesday.

  • Pfizer says AstraZeneca takeover would benefit science Wednesday, 7 May 2014 | 3:54 AM ET

    LONDON, May 7- Pfizer sought to allay fears that its proposed $106 billion takeover of AstraZeneca would deal a blow to drug research, saying the new company would bolster innovative science and speed the development of new treatments. AstraZeneca, Britain's second-largest drugs company, has rejected successive approaches from its larger American rival.

  • *UK could use public interest powers, Business Secretary says. *Lawmakers summon Pfizer, AstraZeneca bosses over takeover bid. LONDON, May 6- Britain could use its public interest powers to intervene in U.S. drugmaker Pfizer's $106- billion takeover bid for British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable said on Tuesday.

  • May 6- Merck& Co Chief Executive Kenneth Frazier said he does not expect a wave of giant mergers in the drug industry despite a spate of recent activity, adding that Merck will seek out promising medicines rather than lower taxes in any future deals.

  • FACTBOX-M&A frenzy transforming global pharma Tuesday, 6 May 2014 | 2:00 PM ET

    MAY May 6- Merck& Co Inc agrees to sell its consumer care business to Germany's Bayer AG for $14.2 billion. May 2- Pfizer Inc raises its offer for AstraZeneca Plc to 63 billion pounds, but the British company promptly rejects the proposal, which would create the world's biggest pharmaceuticals company.

  • Midday movers: Barclays, Pfizer, Twitter & More Tuesday, 6 May 2014 | 12:34 PM ET
    NYSE EuroNext flag hangs outside the NYSE.

    Some of Tuesday's midday movers:

  • LONDON, May 6- Britain could use its public interest powers to intervene in U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable said on Tuesday.

  • Europe stocks close lower on Ukraine, earnings Tuesday, 6 May 2014 | 11:46 AM ET

    European stocks closed lower on Tuesday, as continued violence in Ukraine and mixed earnings results made investors uneasy.

  • LONDON, May 6- AstraZeneca Plc laid out its defence against Pfizer Inc's $106- billion takeover approach on Tuesday by predicting its sales would rise by three quarters over the next decade, although only after a short-term drop. "These are benefits that should fully accrue to AstraZeneca's shareholders."

  • LONDON, May 6- Britain could use its powers to assess whether U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca is in the public interest, Business Secretary Vince Cable said on Tuesday.

  • LONDON, May 6- British lawmakers on Tuesday summoned bosses of U.S. drugmaker Pfizer to explain a $106 billion takeover bid for pharmaceutical firm AstraZeneca which has raised fears over UK jobs, research and intellectual property.

  • LONDON, May 6- Britain's finance minister George Osborne said the government would support a possible takeover of pharmaceutical firm AstraZeneca by U.S. drugmaker Pfizer provided such a deal delivered jobs for Britons.

  • AstraZeneca has issued an update on its strategy to deliver shareholder value, reports CNBC's David Faber. Also, the low borrowing rate is fueling M&A activity, says Faber.

  • *Apple shares in spotlight after closing above $600. *Shares of Office Depot Inc jumped 10 percent in premarket trading even as it reported a quarterly loss and said it would shut at least 400 stores in the United States, hurt by competition from e-retailers, mass market chains and drugstores.

  • LONDON, May 6- AstraZeneca Plc laid out its defence against Pfizer Inc's $106 billion takeover approach on Tuesday by predicting its revenues would rise 75 percent over the next decade, although only after a short-term drop. "These are benefits that should fully accrue to AstraZeneca's shareholders."

  • *Apple shares in spotlight after closing above $600. *Shares of Office Depot Inc jumped 8 percent in premarket trading even as it reported a quarterly loss and said it would shut at least 400 stores in the United States, hurt by competition from e-retailers, mass market chains and drugstores.

  • LONDON, May 6- Britain will continue to speak with U.S. drugmaker Pfizer and British pharmaceutical firm AstraZeneca about any potential takeover but any deal is a commercial decision, Prime Minister David Cameron's spokesman said.

  • Early movers: MRK, GE, DTV, AIG, APC, CS & more Tuesday, 6 May 2014 | 7:54 AM ET
    Traders on the floor of the New York Stock Exchange on April 11, 2014

    Some of the names on the move ahead of the open.

  • AstraZeneca's new attempt to foil Pfizer's plans Tuesday, 6 May 2014 | 7:20 AM ET

    AstraZeneca, the pharmaceutical company fighting off repeated approaches from larger rival Pfizer, has boosted its defense against the raid.

  • LONDON, May 6- Senior management from U.S. drugmaker Pfizer and British pharmaceutical firm AstraZeneca will be called before a British parliamentary committee to answer questions on a potential takeover deal, the committee chairman said on Tuesday.